Specialist in | HCG Oncology

Introduction

Dr. Basavaraj is an experienced clinical radiation oncologist, specializing in advanced technology conventional planning and delivering radiation therapy through various techniques such as 3DCRT, IMRT/IGRT, RapidArc, SRS and SBRT, along with brachytherapy for a broad spectrum of cancers. With a patient-centric approach and a focus on providing the most effective treatment, Dr. Basavaraj's aim is to ensure the best possible outcome for every patient.

Area of Expertise

Dr. Basavaraj's expertise lies in clinical radiation oncology and advanced technology conventional planning and delivering radiation therapy through various techniques, such as 3DCRT, IMRT/IGRT, RapidArc, SRS and SBRT.
He also has hands-on experience in advanced brachytherapy procedures – intracavitary brachytherapy (ICBT) /interstitial brachytherapy (ISBT) and intraluminal brachytherapy for cancers of esophagus, head and neck region, sarcoma and gynaecological malignancies, namely cervical and endometrial cancers.
Dr. Basavaraj has handled over 3500 cases so far

Research & Publications

Dr. Basavaraj has attended numerous events where he has presented his papers and posters and bagged multiple awards:
Presented a poster “Incidence of Vaginal Adhesion in Patients Treated with Radical Radiotherapy in Carcinoma Cervix” December 2013 held in Goa -GOKARNA.
Presented a paper “Incidence of Laryngeal Edema in Head and Neck Cancer Patient Treated with Concurrent Chemoradiation.” AROICON Delhi-2013
Carcinoma oesophagus with Clivus metastasis Case series.
HCG Oncology Mirror April 2017
Incidence of primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland (Free paper) AROICON Bangalore 2018
Presented a Paper “Prospective comparative analysis of Dysphagia in Standard IMRT vs Dysphagia Aspiration Related Structure Sparing IMRT in Head and Neck Cancer. ICC Bangalore

Medical Breakthrough

He is a member of numerous associations, such as the Indian Medical Association, Association of Radiation Oncologist of India, Indian College of Radiation Oncology and Indian Brachytherapy Society.
He has served as an investigator and principal investigator for many clinical trials and below are a few:
Unresectable EGFR mutation-positive Non-Small Cell Lung Cancer (Stage III) whose disease has not progressed following definitive platinum-based chemoradiation therapy (LAURA) (Principal investigator – Ongoing 2018)
Efficacy and safety of Intas Denosumab in comparison with Xgeva in patients with solid tumours with bone metastasis (Co-Investigator)

Other Doctors